Pharmacodynamics articles from across Nature Portfolio Pharmacodynamics (PD) is an area of pharmacology concerned with the relationship between a drug’s concentration at the site of action and ...

Part three of the trial will involve patients at higher risk of cardiovascular disease due to obesity and elevated CRP levels ...

The FDA has accepted for Priority Review the BLA for tividenofusp alfa for the treatment of Hunter syndrome, also known as MPS II.

The trial will evaluate safety, dosing, and efficacy in patients with cardiogenic shock Hennigsdorf/ Berlin, July 23, 2025 – 4TEEN4 Pharmaceuticals GmbH today announced that the first patient has been ...

Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, ...

Senhwa Biosciences begins patient dosing in NCI-sponsored pilot study of Pidnarulex pharmacodynamics in patients with advanced solid tumours: Taipei, Taiwan Thursday, July 17, 202 ...

This study will evaluate the pharmacokinetics, pharmacodynamics, safety and tolerability of a new dosage of ofatumumab compared to the approved dosage of ofatumumab followed by extended treatment in ...

The document comprehensively reviews proton pump inhibitors (PPIs), focusing on their pharmacodynamics, pharmacokinetics, drug interactions, toxicity, and clinical efficacy. PPIs irreversibly inhibit ...

The FDA clears GL-IL2-138, a groundbreaking oral drug modulating natural IL-2, set to revolutionize treatment in oncology.

INTERVENTION Four brands of moist snuff and a non-tobacco mint snuff were tested. Subjects reported to the laboratory for five experimental sessions. After baseline measurement of dependent variables, ...

New approaches reflective of individual responses are required to monitor immunosuppressive therapy and to improve its safety and efficacy. This article reviews some of these approaches.